|
Nobilis Health Corp.
December 17, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased Nobilis Health Corp. (“Nobilis”) (NYSE American: HLTH) securities between May 8, 2018 and November 15, 2018 (the “Class Period”). A complaint has been filed in the United States District Court for the Southern District of Texas against Nobilis, the Company’s CEO, and its former and current CFOs on behalf of investors of Nobilis securities during the Class Period.
|
|
Belden Inc.
December 13, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors who purchased Belden Inc. securities (“Belden” or the “Company”) (NYSE: BDC).
|
|
Cheetah Mobile Inc.
December 7, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Cheetah Mobile Inc. (“Cheetah” or the “Company”) (NYSE: CMCM). Investors who purchased Cheetah securities between April 26, 2017 and November 27, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Southern District of New York against Cheetah, the Company’s CEO, and its CFO on behalf of investors of Cheetah securities during the Class Period.
|
|
Evoqua Water Technologies Corp.
December 4, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Evoqua Water Technologies Corp. (“Evoqua” or the “Company”) (NYSE: AQUA). Investors who purchased Evoqua securities between November 6, 2017 and October 30, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Southern District of New York against Evoqua, the Company’s CEO, and its CFO on behalf of investors of Evoqua securities during the Class Period.
|
|
Aphria Inc.
December 4, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Aphria Inc. (“Aphria” or the “Company”) (NYSE: APHA) concerning potential securities law violations. Investors who purchased Aphria securities may be affected.
|
|
Marriott International, Inc.
November 30, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Marriott International, Inc. (“Marriott” or the “Company”) (NASDAQ: MAR) concerning potential securities law violations. Investors who purchased Marriott securities may be affected.
|
|
Goldman Sachs Group, Inc.
November 14, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Goldman Sachs Group, Inc. (“Goldman Sachs” or the “Company”) (NYSE: GS) concerning potential securities law violations. Investors who purchased Goldman Sachs securities may be affected.
|
|
MoneyGram International, Inc.
November 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of MoneyGram International, Inc. (“MoneyGram” or the “Company”) (NASDAQ: MGI) concerning potential securities law violations. Investors who purchased MoneyGram securities may be affected.
|
|
Yelp, Inc.
November 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors of Yelp Inc. (“Yelp” or the “Company”) (NYSE: YELP).
|
|
Stitch Fix, Inc.
November 8, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Stitch Fix, Inc. (“Stitch Fix” or the “Company”) (NASDAQ: SFIX). Investors who purchased Stitch Fix common stock between June 8, 2018 and October 1, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Northern District of California against Stitch Fix and certain executives on behalf of investors of Stitch Fix common stock during the Class Period.
|
|
NiSource, Inc.
November 8, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of NiSource Inc. (“NiSource” or the “Company”) (NYSE: NI) concerning potential securities law violations. Investors who purchased NiSource securities may be affected.
|
|
Bank OZK
November 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bank OZK (“Bank OZK” or the “Company”) (NASDAQ: OZK). Investors who purchased Bank OZK securities between February 19, 2016 and October 18, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Eastern District of Arkansas against Bank OZK and certain former or current executives on behalf of investors that purchased or otherwise acquired Bank OZK securities during the Class Period.
|
|
Trevena, Inc.
November 2, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Trevena Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN). Investors who purchased Trevena securities between May 2, 2016 and October 9, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Eastern District of Pennsylvania against Trevena and certain executives on behalf of investors that purchased or otherwise acquired Trevena securities during the Class Period.
|
|
Super Micro Computer, Inc.
October 4, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Super Micro Computer, Inc. (“Super Micro” or the “Company”) (OTC: SMCI) concerning potential securities law violations. Investors who purchased Super Micro securities may be affected.
|
|
Geron Corporation
September 27, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Menlo park, California-based Geron Corporation (“Geron” or the “Company”) (Nasdaq: GERN).
|
|
Chegg, Inc.
September 26, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Santa Clara, California-based Chegg, Inc. (“Chegg” or the “Company”) (NYSE: CHGG).
|
|
Microchip Technology, Inc.
September 20, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Microchip Technology Inc. (“Microchip” or the “Company”) (NASDAQ: MCHP). Investors who purchased Microchip common stock between March 2, 2018 and August 9, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Arizona against Microchip and certain executives on behalf of investors that acquired Microchip common stock during the Class Period.
|
|
Pretium Resources, Inc.
September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Pretium Resources, Inc. (“Pretium” or the “Company”) (NYSE: PVG). Investors who purchased Pretium securities between July 21, 2016 and September 6, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Southern District of New York against Pretium and certain executives on behalf of investors that acquired Pretium securities during the Class Period.
|
|
Qurate Retail, Inc.
September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Qurate Retail, Inc. (“Qurate” or the “Company”) (NASDAQ: QRTEA). Investors who purchased Qurate securities between August 5, 2015 and September 7, 2016 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Colorado against Qurate and certain executives on behalf of investors that acquired Qurate securities during the Class Period.
|
|
AbbVie, Inc.
September 18, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of AbbVie Inc. (“AbbVie” or the “Company”).
|
|
OPKO Health, Inc.
September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of OPKO Health, Inc. (“OPKO” or the “Company”) (Nasdaq: OPK).
|
|
USA Technologies, Inc.
September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of USA Technologies, Inc. (“USA Technologies” or the “Company”), which is based in Malverne, Pennsylvania (Nasdaq: USAT).
|
|
Danske Bank A/S
September 11, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating claims on behalf of investors of Danske Bank A/S American Depository Shares (“Danske” or the “Company”) (OTC: DNKEY) (CUSIP: 236363206).
|
|
CV Sciences, Inc.
September 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of CV Sciences, Inc. (“CV Sciences” or the “Company”) (OTC: CVSI). Investors who purchased CV Sciences common stock between June 19, 2017 and August 20, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Nevada against CV Sciences and certain executives on behalf of investors that acquired CV Sciences common stock during the Class Period.
|
|
CBS Corporation
September 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of CBS Corporation (“CBS” or the “Company”) (NYSE: CBS). Investors who purchased CBS securities between February 14, 2014 and July 27, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Southern District of New York against CBS and certain executives on behalf of investors that acquired CBS securities during the Class Period.
|
|
Nevro Corporation
September 6, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Nevro Corporation (“Nevro” or the “Company”) (NYSE: NVRO). Investors who purchased Nevro common stock between January 8, 2018 and July 12, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Northern District of California against Nevro and certain executives on behalf of investors that acquired Nevro common stock during the Class Period.
|
|
Impinj, Inc.
August 22, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Impinj, Inc. (“Impinj” or the “Company”) (NASDAQ: PI). Investors who purchased Impinj securities between May 7, 2018 and August 2, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the Central District of California against Impinj and certain executives on behalf of investors that acquired Impinj securities during the Class Period.
|
|
Sinclair Broadcast Group, Inc.
August 10, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Sinclair Broadcast Group, Inc. (“Sinclair” or the “Company”) (NASDAQ: SBGI). Investors who purchased Sinclair securities between February 22, 2017 and July 19, 2018 (the “Class Period”) may be affected. A complaint has been filed in the United States District Court for the District of Maryland against Sinclair and certain executives of the Company on behalf of investors that purchased or otherwise acquired Sinclair common stock during the Class Period.
|
|
Tesla, Inc.
August 9, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Tesla, Inc. (“Tesla” or the “Company”) (NASDAQ: TSLA) concerning potential securities law violations. Investors who purchased Tesla securities may be affected.
|
|
Ampio Pharmaceuticals, Inc.
August 8, 2018 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Ampio Pharmaceuticals, Inc. (“Ampio” or the “Company”) (NYSE: AMPE) concerning potential securities law violations. Investors who purchased Ampio securities may be affected.
|
